The Use of Juçara (Euterpe edulis Mart.) Supplementation for Suppression of NF-κB Pathway in the Hypothalamus after High-Fat Diet in Wistar Rats.
Aline Boveto SantamarinaGiovana JamarLaís Vales MennittiVeridiana Vera De RossoHelena Cassia CesarLila Missae OyamaLuciana Pellegrini PisaniPublished in: Molecules (Basel, Switzerland) (2018)
Obesity is associated with modern diets that are rich in saturated fatty acids. These dietary patterns are linked to low-grade proinflammatory mechanisms, such as the toll-like receptor 4/nuclear factor kappa-B (NF-κB) pathway rapidly activated through high-fat diets. Juçara is a berry rich in anthocyanins and unsaturated fatty acids, which prevents obesity and associated comorbidities. We evaluated the effect of different doses of freeze-dried juçara pulp on NF-κB pathway after the consumption of short-term high-fat diet. Male Wistar rats with ad libitum access to food and water were divided into four groups: Control diet (C), high-fat diet (HFC), high-fat diet with 0.25% juçara (HFJ 0.25%), and high-fat diet with 0.5% juçara (HFJ 0.5%). Energy intake and body weight gain were increased in HFC and HFJ 0.5% groups compared to C group. The hypothalamus weight reduced in the HFC group compared to C and HFJ 0.25% groups. Cytokines, MYD88, TRAF6, and pNF-κBp50 levels in the hypothalamus, serum triacylglycerol, LDL-cholesterol (LDL-C), and free fatty acid levels were improved in the HFJ 0.25% group. In summary, the HFJ 0.25% group had better protective effects than those in the HFJ 0.5%. Therefore, 0.25% juçara can be used to protect against central inflammation through the high-fat diet-induced NF-κB pathway.
Keyphrases
- high fat diet
- nuclear factor
- toll like receptor
- insulin resistance
- weight gain
- high fat diet induced
- fatty acid
- weight loss
- adipose tissue
- low grade
- metabolic syndrome
- inflammatory response
- body mass index
- skeletal muscle
- birth weight
- immune response
- type diabetes
- oxidative stress
- signaling pathway
- high grade
- lps induced
- low density lipoprotein
- risk assessment
- pi k akt
- physical activity